Dr. Sanjeev Kumar, MD
Claim this profileCentre for Addiction and Mental Health
Studies Alzheimer's Disease
Studies Dementia
4 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Sanjeev Kumar, MD is currently running
tDCS
for Alzheimer's Dementia
Agitation and aggression impose a tremendous burden on the individuals living with dementia, their families, caregivers, and healthcare systems. Neuropsychiatric symptoms of dementia (NPS) affect up to 80% of patients with Alzheimer's dementia (AD). The mechanisms of agitation in AD are poorly understood and the current interventions are only modestly effective while having serious adverse effects. In this study, the investigators propose to assess the mechanisms and treatment of neuropsychiatric symptoms in AD with the use of non-invasive, brain stimulation approaches. By applying magnetic stimulation to the surface of the head (transcranial magnetic stimulation - TMS) combined with electroencephalography (EEG), the investigators will be able to study the mechanisms of agitation and advance our understanding of AD. Further, the investigators will evaluate if transcranial direct current stimulation (tDCS) is effective to treat agitation dementia.
Recruiting0 awards N/A6 criteria
Neurostimulation
for Mild Cognitive Impairment
More than 5 million people live with Alzheimer's dementia (AD) in North America. No effective treatment exists yet probably because by the time AD has developed it is too late to intervene. Mild Cognitive Impairment (MCI) is a clinical state that typically precedes AD. In MCI, the prefrontal cortex supports compensatory mechanisms that depend on robust synaptic plasticity and that delay progression to AD. Using a neurostimulation approach that enhances prefrontal cortical plasticity in vivo, this project aims to enhance prefrontal cortical plasticity and function in patients with MCI. If successful, this project would discover a treatment modality that enhances compensation in MCI and ultimately, prevents progression to AD.
Recruiting0 awards N/A13 criteria
More about Sanjeev Kumar, MD
Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Sanjeev Kumar, MD has experience with
- Paired Associative Stimulation (PAS)
- TDCS
- Non-Pharmacological Intervention
- Pharmacological Intervention
Breakdown of trials Sanjeev Kumar, MD has run
Alzheimer's Disease
Dementia
Mild Cognitive Impairment
Alzheimer's Dementia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sanjeev Kumar, MD specialize in?
Sanjeev Kumar, MD focuses on Alzheimer's Disease and Dementia. In particular, much of their work with Alzheimer's Disease has involved treating patients, or patients who are undergoing treatment.
Is Sanjeev Kumar, MD currently recruiting for clinical trials?
Yes, Sanjeev Kumar, MD is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Sanjeev Kumar, MD has studied deeply?
Yes, Sanjeev Kumar, MD has studied treatments such as Paired Associative Stimulation (PAS), tDCS, Non-Pharmacological Intervention.
What is the best way to schedule an appointment with Sanjeev Kumar, MD?
Apply for one of the trials that Sanjeev Kumar, MD is conducting.
What is the office address of Sanjeev Kumar, MD?
The office of Sanjeev Kumar, MD is located at: Centre for Addiction and Mental Health, Toronto, Ontario M6J 1H4 Canada. This is the address for their practice at the Centre for Addiction and Mental Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.